Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
Conditions:   Streptococcal Pneumonia;   HIV/AIDS Intervention:   Biological: Prevenar13 Sponsor:   Korea University Guro Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2019 Category: Research Source Type: clinical trials